What Researchers Did
Researchers reported a case of a 42-year-old patient who developed acute respiratory distress syndrome (ARDS) after prolonged hyperbaric oxygen therapy for severe decompression illness.
What They Found
A 42-year-old patient with severe decompression illness developed ARDS following very long hyperbaric oxygen therapy using a US Navy Treatment Table 7. The ARDS progressed to pulmonary fibrosis, and the patient ultimately died despite maximal intensive care unit support. This case highlights the potential for pulmonary oxygen toxicity during extended recompression treatments.
What This Means for Canadian Patients
Canadian patients undergoing prolonged hyperbaric oxygen therapy for conditions like severe decompression illness should be monitored closely for signs of pulmonary oxygen toxicity. Healthcare providers should consider the potential for acute respiratory distress syndrome and subsequent pulmonary fibrosis when administering extended recompression treatments.
Canadian Relevance
This study has no direct Canadian connection as it is a case report from France. However, the medical principles regarding hyperbaric oxygen therapy and its risks are universally applicable.
Study Limitations
As a single case report, the findings cannot be generalized to a larger patient population.